Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
70 Cards in this Set
- Front
- Back
|
LIST FLOW CHART TO NERVOUS SYSTEM
|
/ \ CNS PNS / \ AUTONOMIC SOMATIC / \ SYMPATHETIC PARASYMPATHETIC (GAS) (BREAK) |
|
|
PERIPHIAL NERVOUS SYSTEM
|
ALL NERVOUS TISSUE OUTSIDE THE CENTRAL NERVOUS SYSTEM |
|
|
CENTRAL NERVOUS SYSTEM
|
CONSISTS OF THE BRAIN AND SPNAL CORD |
|
|
AUTONOMIC NERVOUS SYSTEM
|
PART OF THE PERIPHIAL NERVOUS SYSTEM AND CONTROLS CRUCIAL CARDIO, RESP, DIGESTIVE, AND REPRODUCTIVE FUNCTIONS "AUTOMATIC" |
|
|
SOMATIC NERVOUS SYSTEM
|
CONTROLS VOLUNTARY "MOTOR" FUNCTIONS |
|
|
SYMPATHETIC NERVOUS SYSTEM
|
ARISES FROM THORACIC AND LUMBAR REGION OF SPINE |
|
|
PARASYMPATHETIC NERVOUS SYSTEM |
FEED AND BREED OR REST AND DIGEST RESPONCE CONTROLS VEGITATIVE FUNCTIONS I.E. DIGESTION ARISES FROM BRAIN STEM AND SACRAL REGION OF SPINAL CORD (RUN THROUGH THE FACIAL NERVES) |
|
|
ACETYLCHOLINE (ACh)
|
USED IN THE PREGANGLIONOC NERVES OF THE PARASYMPATHETIC NERVOUS SYSTEM. SYNAPSES THAT USE IT ARE CALLED CHOLINERGIC |
|
|
NOREPINEPHERINE (NATURALLY OCCURING)
|
HORMONE PRIMARY POSTGANGLIONIC TRANSMITTER IN SYMPATHETIC NERVOUS SYSTEM. SYNAPSES THAT USE IT ARE CALLED ADREGENIC CONSTITUTE 20% OF WHAT IS RELEASED BY ADRENAL MEDELLA |
|
|
α1 RECEPTOR
|
CAUSE PERIPHIAL VASO CONSTRICTION |
|
|
α2 RECEPTOR |
INHIBIT THE OVERRELEASE OF NOREPINEPHERINE IN THE SYNAPSE |
|
|
ß1 RECEPTORS |
CAUSE AN INCREASE IN HEART RATE, CARDIAC CONTRACTILITY FORCE, AND CARDIAC AUTOMATICITY AND CONDUCTION |
|
|
ß2 RECEPTORS
|
CAUSE VASODIALATION AND BRONCHODIALATION |
|
|
ß3 RECEPTORS
|
CAUSES BREAKDOWN OF FAT AND GENERATION OF HEAT
|
|
|
SYMPATHOMIMETICS
|
MEDICATIONS THAT ACT ON THE SYMPATHETIC NERVOUS SYSTEM |
|
|
SYMPATHOLYTICS |
MEDICATIONS THAT INHIBIT SYMPATHETIC NERVOUS SYSTEM FUNCTIONS |
|
|
PARASYMPATHOLYTIC (ANTICHOLINERGENIC)
|
I.E. ATROPINE |
|
|
PARASYMPATHEMEMIC (CHOLINERGENIC) |
MEDICATIONS THAT ACT ON THE ACTIONS OF THE PARASYMPATHETIC NERVOUS SYSTEM
|
|
|
ADRENAL MEDELLA
|
ENDOCRINE GLAND THAT SITS ATOP THE KIDNEY AND SECRETES EPI AND NOREPI |
|
|
EPINEPHERINE |
VASOCONSTICTOR ↑HR ↑BP ↑CARDIAC CONTRACTILITY FORCE |
|
|
NOREPINEPHERINE |
PERIPHIAL VASO CONSTRICTER ↑BP IN CARDIOGENIC SHOCK AND HYPOTENSIVE EMERGENCIES AS LONG AS IT IS NOT RELATED TO HYPOVOLEMIA |
|
|
ATRPOINE
|
Primary agent in organophosphate poisoning
|
|
|
MEDICATION NAMES
|
CHEMICAL: CHEMICAL MAKEUP OF THE DRUG BRAND NAME:TRADE NAME, DEVELOPED BY COMPANY IDENTIFIES AS PROPRIATARY PROPERTY USUALY WITH COPYRIGHT SYMBOL GENERIC: SHORTHAND VERSION OF THE CHEMICAL NAME LESS EXPENSIVE BUT SAME QUALITY |
|
|
DRUG ADMINISTRATION ROUTES |
PARENTRAL: LIQUID DOES NOT PASS THROUGH THE G.I. TRACT I.V. I.O. I.M. SUB Q ORAL: THROUGH THE MOUTH BUCCAL: BETWEEN MOUTH AND CHEEK ON MUCOS MEMBRANES RECTAL: YOU KNOW WHERE ETT: ET TUBE |
|
|
PHARMACOKINETICS |
THE STUDY OF HOW A DRUG ENTERS MOVES THROUGH, AND EXITS THE BODY |
|
|
PHARMACODYNAMICS |
THE STUDY OF A DRUGS EFFECTS ON THE BODY |
|
|
OSMOSIS |
A MOLECULE MOVING ACROSS A MEMBRANE |
|
|
DIFFUSION |
MOLOCULES INTERMINGLEING |
|
|
ACTIVE TRANSPORT |
THE MOVEMENT OF A SUBSTANCE WITH THE HELP OF ENERGY
|
|
|
FACILITATED TRANSPORT
|
THE MOVEMENT OF A SUBSTANCE WITHOUT THE USE OF ENERGY |
|
|
INFILTRATION
|
"BLOWING" THE VEIN OR GOING THROUGH THE VEIN AND PERFUSING FLUIDS IN THE TISSUE OUTSIDE THE VEIN |
|
|
CLOT OBSTRUCTION
|
CAN BE FORMED IF A SALINE LOCK IS NOT USED AFTER I.V. ACCESS HAS BEEN ACHIEVED, OR A FLUSH HAS NOT BEEN PERFORMED |
|
|
COLLOID |
SOLUTION THAT CONTAINs LARGE PROTINES THAT CANNOT PASS THROUGH THE CAPLIARY MEMBRANE. REMAIN IN THE CIRCULATORY SYSTEM FOR A LONG TIME I.E. PLASMANATE,DEXTRAN,HESPAN |
|
|
CRYSTALLOID |
I.E. LACTATED RINGERS* * BOTH WILL HAVE 2/3 LOSS IN EXTRACELLULAR SPACE WITHIN 1HR NORMAL SALINE* 5% DEXTROSE IN WATER |
|
|
ISOTONIC SOLUTION |
EQUAL TO BLOOD PLASMA WILL NOT CAUSE SIGNIFICANT ELECTROLYTE OR FLUID SHIFT |
|
|
HYPERTONIC SOLUTION |
HIGHER CONCENTRATION THAN THAT OF THE CELLS WHEN ADMINISTERED THEY WILL CAUSE FLUID TO SHIFT OUT OF THE INTERCELLULAR SPACE INTO THE EXTRACELLULAR SPACE AND WILL DIFFUSE LATER IN REVERSE ORDER |
|
|
HYPOTONIC SOLUTION |
LOWER CONCENTRATION THAN THAT OF THE CELLS. WHEN ADMINISTERED THEY WILL CAUSE FLUID TO SHIFT OUT OF THE EXTRACELLULAR SPACE INTO THE INTERCELLULAR SPACE AND WILL DIFUSE LATER IN REVERSE ORDER |
|
|
INTRAOSEOUS ROUTE |
I.O. SITES ARE IN THE PROXIMAL TIBIA, MEDIAL MALLEOLUS OF THE DISTAL TIBIA, HUMERAL HEAD, AND STERNUM INDICATED WHEN I.V. ACCESS CANNOT BE OBTAINED CONTRAINDICATED IN FRACTURE ON SIDE OF ACCESS, OSTEOPOROSIS AND ESTABLISHMENT OF A PERIPHIAL I.V. SITE |
|
|
INTRADERMAL INJECTION |
10-15° ANGLE 25-27GUAGE FOREARM OR UPPER BACK DO NOT RUB LOCAL RESPONSE |
|
|
SUBCUTANEOUS INJECTION
|
45° ANGLE WHERE YOU CAN EASILY PINCH SKIN UPPER ARMS, THIGHS AND OCCASIONALY ABDOMEN 24-26 GUAGE |
|
|
INTRAMUSCULAR INJECTION |
90° ANGLE DELTIOD MUSCLE 3-4 FINGERBREADTHS BELOW SHOULDER BUTT, THIGH 21-23 GUAGE |
|
|
OCULAR MEDICATION DELIVERY |
APPLY MEDICATION DROPS OR GEL ONTO CONJUNCTIVE SAC NOT ON EYE ITSELF UNLESS SPECIFICALLY INSTRUCTED. TELL PT. TO HOLD EYE SHUT FOR 1-2 MIN. O.D. RIGHT O.S.LEFT O.U. BOTH |
|
|
AURAL MEDICATION DELIVERY
|
ADMINISTER DROPS INTO EAR CANAL, HAVE PT LAY ON SIDE FOR 10 MIN |
|
|
SLUDGE
|
ORGANOPHOSPHATE POISIONING CAUSES SLOWED HEART RATE CYANOSIS VOMITING AND DIARRHEA |
|
|
ORGANPHOSPHATE POISIONING TREATMENT
|
ATROPINE, 2PAM (PRALIDOXIME), BENZODIAZEPINES (DIAZEPAM) |
|
|
AXON
|
USUALLY A LONG PROCESS WHICH OFTEN PROJECTS TO DISTANT REGIONS OF THE NERVOUS SYSTEM. AWAY FROM THE CELL BODY |
|
|
DENDRITES |
SHORT BRANCH LIKE PROCESS WHICH BRINGS SIGNALS TO THE CELL BODY |
|
|
CELL BODY
|
CELL |
|
|
MYELIN SHEATH |
FATTY WHITE SUBSTANCE THAT SURROUNDS THE AXON SERVING AS AN ELECTRICAL INSULATOR THAT SPEEDS NERVE IMPULSES TO MUSCLES AND OTHER EFFECTORS |
|
|
DRUG SOURCES (4 TYPES) |
PLANT:MORPHINE, ATROPINE MINERAL:SODIUM BICARB, CALCIUM CHLORIDE SYNTHETIC:ADENOSINE,DIAZEPAM,HEP. B VACC. |
|
|
CROSS TOLERENCE
|
TOLERENCE FOR A DRUG THAT DEVELOPS AFTER ADMINISTRATION OF A DIFFERENT DRUG I.E. MORPHINE AND OPIODS
|
|
|
POTENTIATION
|
ENHANCEMENT OF ONE AGENT BY ANOTHER SO THE COMBINED EFFECT IS GREATER THAN THAT ONE AGENT ALONE. |
|
|
ACTION POTENTIAL |
THE CHANGE IN ELECTRICAL POTENTIAL ASSOCIATED WITH THE PASSAGE OF AN IMPULSE ALONG THE MEMBRANE OF A MUSCLE/NERVE CELL |
|
|
PROPAGATE
|
TO CAUSE AN ORGANISM TO MULTIPLY BY ANY PROCESS FROM PARENT STOCK. (TO PRODUCE A NEW PLANT) |
|
|
DEPOLARIZATION |
REDUCTION OF A MEMBRANES RESTING POTENTIAL BECOMING LESS NEGATIVE (IONS FLOWING INTO A CELL)
|
|
|
REPOLAROZATION
|
REFERS TO THE CHANGE IN MEMBRANE POTENTIAL THAT RETURNS TO NEGATIVE VALUE AFTER DEPOLARIZATION |
|
|
SYNTHISIS |
PRODUCTION OF CHEMICAL COMPOUNDS BY COMBINING PARTS OF AN ELEMENT FROM A WHOLE |
|
|
TRANSMISSION
|
TO PASS ALONG, OR THE ACT OF TRANSMITTING |
|
|
ENDOGENOUS |
GROWING OR ORIGINATING FROM AN ORGANISIM |
|
|
PRE-SYNAPTIC |
CELL THAT TRANSMITTS |
|
|
POST-SYNAPTIC |
CELL THAT RECEIVES
|
|
|
SYNAPSE
|
A STRUCTURE THAT PERMITS A NEURON TO PASS A TRANSMISSION TO ANOTHER |
|
|
DOPAMINERGIC |
↑ DOPAMINE RELATED ACTIVITY IN THE BRAIN
|
|
|
METHYLPHENIDATE |
(RITALIN) USED FOR ADHD |
|
|
DILANTIN |
TREATMENT OF GRAND MAL SIEZURES |
|
|
MORPHINE SULPHATE |
SEDATION BY BINDING TO OPIATE RECEPTORS. NALOXONE ↓ BP, SYNCOPE, TACHY/BRADYCARDIA |
|
|
TRICYCLIC ANTIDEPRESSANTS
|
ANTIDEPRESSANTS THAT CAUSE SIDE EFFECTS
|
|
|
EXTRA PYRAMIDAL SYMPTOMS
|
MUSCLE TREMORS AND PARKINSINISIM LIKE EFFECTS |
|
|
MAOI |
AVOID RED WINE, AGED CHEESE |
|
|
XANEX |
BENZODIAZEPINE;ROMAZICON IS THE ANTAGONIST TO IT. AVOID ITS USE IF SEIZURES EXIST |
